Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL.

JAMA. 2010 Dec 8;304(22):2494-502. doi: 10.1001/jama.2010.1708. Epub 2010 Nov 15.

2.

Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.

Glick D, deFilippi CR, Christenson R, Gottdiener JS, Seliger SL.

JACC Heart Fail. 2013 Aug;1(4):353-360. doi: 10.1016/j.jchf.2013.04.007. Epub 2013 Aug 5.

3.

Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing.

Xiao W, Cao R, Liu Y, Wang F, Bai Y, Wu H, Ye P.

BMJ Open. 2017 Jun 26;7(6):e013431. doi: 10.1136/bmjopen-2016-013431.

4.

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.

Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM.

Circulation. 2011 Apr 5;123(13):1367-76. doi: 10.1161/CIRCULATIONAHA.110.005264. Epub 2011 Mar 21.

5.

Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK.

JAMA. 2010 Dec 8;304(22):2503-12. doi: 10.1001/jama.2010.1768. Erratum in: JAMA. 2011 Mar 23;305(12):1200.

6.

Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults.

Hussein AA, Bartz TM, Gottdiener JS, Sotoodehnia N, Heckbert SR, Lloyd-Jones D, Kizer JR, Christenson R, Wazni O, deFilippi C.

Heart Rhythm. 2015 May;12(5):879-85. doi: 10.1016/j.hrthm.2015.01.020. Epub 2015 Jan 17.

7.

High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.

Beatty AL, Ku IA, Christenson RH, DeFilippi CR, Schiller NB, Whooley MA.

JAMA Intern Med. 2013 May 13;173(9):763-9. doi: 10.1001/jamainternmed.2013.116.

8.

Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.

Neeland IJ, Drazner MH, Berry JD, Ayers CR, deFilippi C, Seliger SL, Nambi V, McGuire DK, Omland T, de Lemos JA.

J Am Coll Cardiol. 2013 Jan 15;61(2):187-95. doi: 10.1016/j.jacc.2012.10.012. Epub 2012 Dec 5.

9.

Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults.

deFilippi CR, de Lemos JA, Tkaczuk AT, Christenson RH, Carnethon MR, Siscovick DS, Gottdiener JS, Seliger SL.

J Am Coll Cardiol. 2012 Dec 18;60(24):2539-47. doi: 10.1016/j.jacc.2012.08.1006. Epub 2012 Nov 14.

10.

Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.

McEvoy JW, Chen Y, Ndumele CE, Solomon SD, Nambi V, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E.

JAMA Cardiol. 2016 Aug 1;1(5):519-28. doi: 10.1001/jamacardio.2016.0765.

11.

Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.

Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R; Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca–Heart Failure (GISSI-HF) Investigators.

Circulation. 2012 Jan 17;125(2):280-8. doi: 10.1161/CIRCULATIONAHA.111.044149. Epub 2011 Dec 2.

12.

Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).

Seliger SL, de Lemos J, Neeland IJ, Christenson R, Gottdiener J, Drazner MH, Berry J, Sorkin J, deFilippi C.

JACC Heart Fail. 2015 Jun;3(6):445-455. doi: 10.1016/j.jchf.2014.12.018. Epub 2015 May 14.

13.

Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.

Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, Greenberg BH, Filippatos G, Davison BA, Cotter G, Prescott MF, Hua TA, Lopez-Pintado S, Severin T, Metra M.

Eur J Heart Fail. 2015 Dec;17(12):1262-70. doi: 10.1002/ejhf.341. Epub 2015 Sep 3.

14.

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.

Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP, Tognoni G, Cohn JN; Val-HeFT Investigators.

Circulation. 2007 Sep 11;116(11):1242-9. Epub 2007 Aug 13.

15.

Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis.

Parikh RH, Seliger SL, de Lemos J, Nambi V, Christenson R, Ayers C, Sun W, Gottdiener JS, Kuller LH, Ballantyne C, deFilippi CR.

Clin Chem. 2015 Dec;61(12):1524-31. doi: 10.1373/clinchem.2015.244160. Epub 2015 Oct 27.

16.

Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.

de Antonio M, Lupón J, Galán A, Vila J, Zamora E, Urrutia A, Díez C, Coll R, Altimir S, Bayes-Genis A.

Clin Chim Acta. 2013 Nov 15;426:18-24. doi: 10.1016/j.cca.2013.08.014. Epub 2013 Aug 23.

PMID:
23978483
17.

Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure.

Takashio S, Yamamuro M, Izumiya Y, Sugiyama S, Kojima S, Yamamoto E, Tsujita K, Tanaka T, Tayama S, Kaikita K, Hokimoto S, Ogawa H.

J Am Coll Cardiol. 2013 Aug 13;62(7):632-40. doi: 10.1016/j.jacc.2013.03.065. Epub 2013 May 1.

18.

Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.

Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J; CORONA Study Group.

Circ Heart Fail. 2014 Jan;7(1):96-103. doi: 10.1161/CIRCHEARTFAILURE.113.000450. Epub 2013 Nov 27.

19.

Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.

Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele CE, Solomon SD, Bozkurt B, Selvin E, Ballantyne CM, Deswal A.

JACC Heart Fail. 2017 Jan;5(1):56-63. doi: 10.1016/j.jchf.2016.10.010. Epub 2016 Dec 21.

20.

Troponin T as a Predictor of End-Stage Renal Disease and All-Cause Death in African Americans and Whites From Hypertensive Families.

Hickson LJ, Rule AD, Butler KR Jr, Schwartz GL, Jaffe AS, Bartley AC, Mosley TH Jr, Turner ST.

Mayo Clin Proc. 2015 Nov;90(11):1482-91. doi: 10.1016/j.mayocp.2015.08.016. Epub 2015 Oct 19.

Supplemental Content

Support Center